New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 12, 2014
09:23 EDTRPRXRepros Therapeutics reports Q1 EPS (37c), consensus (35c)
Total revenues and other income increased to $2,000 for the three month period ended March 31 as compared to $1,000 for the same period in the prior year. This increase was due to an increase in interest income as a result of higher cash balances.
News For RPRX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
March 24, 2015
14:18 EDTRPRXRepros Therapeutics April volatility elevated at 144
Repros Therapeutics April call option implied volatility is at 144, May is at 108, August is at 107; compared to its 26-week average of 103 according to Track Data, suggesting large near term price movement

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use